(Q40100883)

17 September 2017

1 reference

title

Ribavirin and inosiplex: a review of their present status in viral diseases (English)

1 reference

17 September 2017

1 reference

T W Chang

1

1 reference

17 September 2017

R C Heel

series ordinal

2

1 reference

17 September 2017

publication date

1 August 1981

1 reference

17 September 2017

1 reference

17 September 2017

volume

22

1 reference

17 September 2017

issue

2

1 reference

17 September 2017

page(s)

111-128

1 reference

Antiviral, immunosuppressive and antitumour effects of Ribavirin

17 September 2017

cites work

1 reference

12 December 2020

Studies on the mechanism of antiviral action of 1-(.beta.-D-ribofuranosyl)-1,2,4-triazole-3-carboxamide (ribavirin)

1 reference

12 December 2020

Response of influenza virus-infected mice to selected doses of ribavirin administered intraperitoneally or by aerosol

1 reference

12 December 2020

In vitro effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses

1 reference

12 December 2020

Effect of Ribavirin on Murine Cytomegalovirus Infection

1 reference

12 December 2020

Clinical evaluation of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) in a double-blind study during an outbreak of influenza

1 reference

12 December 2020

Effect of cytosine, arabinoside, iododeoxyuridine, ethyldeoxyuridine, thiocyanatodeoxyuridine, and ribavirin on tail lesion formation in mice infected with vaccinia virus

1 reference

12 December 2020

Effect of Isoprinosine Against Influenza and Some Other Viruses Causing Respiratory Diseases

1 reference

12 December 2020

The broad spectrum antiviral agent ribavirin inhibits capping of mRNA

1 reference

12 December 2020

Trial of the antiviral action of isoprinosine against rhinovirus infection of volunteers

1 reference

12 December 2020

Comparative clinical and laboratory evaluation of the prophylactic capacity of ribavirin, amantadine hydrochloride, and placebo in induced human influenza type A

1 reference

12 December 2020

Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: A controlled study

1 reference

12 December 2020

Therapeutic Effects of Small-Particle Aerosols of Ribavirin on Parainfluenza (Sendai) Virus Infections of Mice

1 reference

12 December 2020

Failure of type 1 herpesvirus to develop resistance to ribavirin

1 reference

12 December 2020

Virazole (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide; a cytostatic agent.

1 reference

12 December 2020

Antiviral effects of virazole in chronic hepatitis B surface antigen-seropositive chimpanzees

1 reference

12 December 2020

The antiviral activity of isoprinosine

1 reference

12 December 2020

Failure of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) to stimllate interferon

1 reference

12 December 2020

Lack of effect of oral ribavirin in naturally occurring influenza A virus (H1N1) infection

1 reference

12 December 2020

Lack of suppression of resistance factors to influenza infections in mice pretreated with virazole

1 reference

12 December 2020

Synthesis and antiviral activity of some phosphates of the broad-spectrum antiviral nucleoside, 1-.beta.-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin)

1 reference

12 December 2020

Therapeutic efficacy of inosiplex (Isoprinosine) in rhinovirus infection

1 reference

12 December 2020

Effects of Small-Particle Aerosols of Rimantadine and Ribavirin on Arterial Blood pH and Gas Tensions and Lung Water Content of A2 Influenza-Infected Mice

1 reference

12 December 2020

Biochemistry and biological effects of the pyrazofurins (pyrazomycins): initial clinical trial

1 reference

12 December 2020

Inosiplex for Localized Herpes Zoster in Childhood Cancer Patients: Preliminary Controlled Study

1 reference

12 December 2020

Selective inhibition of RNA tumor virus replication in vitro and evaluation of candidate antiviral agents in vivo

1 reference

12 December 2020

A New Class of Synthetic Nucleoside Analogues with Broad-spectrum Antiviral Properties

1 reference

12 December 2020

In vitro effect of virazole against influenza viruses

1 reference

12 December 2020

The enzymic conversion of 1,2,4-triazole-3-carboxamide to ribavirin-5'-phosphate and its relationship to the proposed mechanism of action

1 reference

12 December 2020

Antiviral Activity of Ribavirin in Rotavirus Gastroenteritis of Mice

1 reference

12 December 2020

In vitro and in vivo effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) on types 1 and 3 parainfulenza virus infections

1 reference

12 December 2020

In vitro antiviral efficacy of ribavirin against feline calicivirus, feline viral rhinotracheitis virus, and canine parainfluenza virus

1 reference

12 December 2020

A plaque assay for the study of influenza virus inhibitors

1 reference

12 December 2020

Differntiation and Regulation of Lymphocyte Populations: Evidence for Immunopotentiator-Induced T Cell Recruitment

1 reference

12 December 2020

Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin

1 reference

12 December 2020

Design, synthesis, and broad spectrum antiviral activity of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide and related nucleosides

1 reference

12 December 2020

Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate

1 reference

12 December 2020

Effect of Isoprinosine Against Challenge with A(H 3 N 2 )/Hong Kong Influenza Virus in Volunteers

1 reference

12 December 2020

Antiviral mechanisms of action

1 reference

12 December 2020

Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide

1 reference

12 December 2020

Virazole prevents production of Sindbis virus and virus-induced cytopathic effect in Aedes albopictus cells

1 reference

12 December 2020

The relative potencies of anti-influenza compounds

1 reference

12 December 2020

Inosiplex: an immunomodulation model for the treatment of viral disease

1 reference

12 December 2020

Double-blind evaluation of oral ribavirin (Virazole) in experimental influenza A virus infection in volunteers

1 reference

12 December 2020

Isoprinosine: an overview

1 reference

12 December 2020

Double-blind clinical assessment of ribavirin (virazole) in the prevention of induced infection with type B influenza virus

1 reference

12 December 2020

Suppression by 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) of influenza virus-induced infections in mice

1 reference

12 December 2020

Antiviral activity of isoprinosine in vitro and in vivo

1 reference

12 December 2020

In vitro studies on cell-mediated immunity in patients treated with inosiplex for herpes virus infection

1 reference

12 December 2020

Inosiplex, a stimulating agent for normal human T cells and human leukocytes

1 reference

12 December 2020

Metabolism of 5-amino-1-β-d-ribofuranosyl- imidazole-4-carboxamide and related five-membered heterocycles to 5′-triphosphates in human blood and L5178Y cells

1 reference

12 December 2020

Isoprinosine: lack of antiviral activity in experimental model infections

1 reference

12 December 2020

Adenosine kinase initiates the major route of ribavirin activation in a cultured human cell line

1 reference

12 December 2020

Specific inhibitors of influenza virus replication as potential chemoprophylactic agents

1 reference

12 December 2020

Isoprinosine augmentation of phytohemagglutinin-induced lymphocyte proliferation

1 reference

12 December 2020

Efficacy of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide against influenza virus infections in mice

1 reference

12 December 2020

Effect of ribavirin on Type 2 Herpesvirus hominis (HVH/2) in vitro and in vivo

1 reference

12 December 2020

Anti-herpesvirus action of isoprinosine

1 reference

12 December 2020

Evaluation of isoprinosine in experimental human rhinovirus infection

1 reference

12 December 2020

Enhancement of antiviral protection against encephalomyocarditis virus by a combination of isoprinosine and interferon

1 reference

12 December 2020

Inhibition of vaccinia virus growth by the nucleoside analogue 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ribavirin)

1 reference

12 December 2020

Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent

1 reference

12 December 2020

Inhibition of lymphocyte proliferative responses by ribavirin.

1 reference

12 December 2020

The relationship between the metabolism of ribavirin and its proposed mechanism of action

1 reference

12 December 2020

10.2165/00003495-198122020-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

17 September 2017

1029303413

0 references

1 reference